Cargando…
Managing metastatic renal cell carcinoma-challenges, pitfalls, and outcomes in the real world
INTRODUCTION: Renal cell carcinoma (RCC) is the most common cancer of the kidney accounting for 85% of renal tumors. Metastatic RCC (mRCC) had a poor prognosis and with the introduction of tyrosine-kinase inhibitors, such as sunitinib, pazopanib the outcomes improved. There is only one study reporte...
Autores principales: | Kumar, Karnam Ashok, Sadashivudu, Gundeti, Krishnamani, K. V., Linga, Vijay Gandhi, Maddali, Lakshmi Srinivas, Digumarti, Raghunadha Rao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234163/ https://www.ncbi.nlm.nih.gov/pubmed/28144093 http://dx.doi.org/10.4103/0971-5851.195738 |
Ejemplares similares
-
Clinicopathological features and outcomes in advanced nonsmall cell lung cancer with tailored therapy
por: Bala, Stalin, et al.
Publicado: (2016) -
Effectiveness of Three Prognostic Scoring Systems in Predicting the Response and Outcome in Pediatric Chronic Myeloid Leukemia Chronic Phase on Frontline Imatinib
por: Ganta, Ranga Raman, et al.
Publicado: (2017) -
Epedimiologic, clinical profile and factors affecting the outcome in febrile neutropenia
por: Krishnamani, Kalpathi, et al.
Publicado: (2017) -
Prevalence and outcome of epidermal growth factor receptor mutations in non-squamous non-small cell lung cancer patients
por: Kota, Rajesh, et al.
Publicado: (2015) -
Primary pleuropulmonary synovial sarcoma: A report of two cases and review of literature
por: Kalpathi, Krishnamani, et al.
Publicado: (2013)